ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Sjogren’s syndrome"

  • Abstract Number: 3227 • 2016 ACR/ARHP Annual Meeting

    Modelling Primary Sjögren’s Syndrome Using Salivary Gland Stem Cells

    Sarah Pringle1, Hendrika Bootsma2, Arjan Vissink3, Fred K.L. Spijkervet4, Robert Coppes5 and Frans G.M. Kroese6, 1Rheumatology and Clinical Immunology, University Medical Centrum Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands, 3Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Radiation Oncology and Cell Biology, University Medical Centrum Groningen, Groningen, Netherlands, 6Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Primary Sjögren’s Syndrome (pSS) is characterized by lymphocytic infiltration of salivary glands.  Unclear interactions between infiltrating cells and salivary gland ductal cells cause reduced…
  • Abstract Number: 66 • 2016 ACR/ARHP Annual Meeting

    Very Rare X Chromosome Abnormalities in SLE and SjöGren’s May Localize X Gene Dose Effect

    Rohan Sharma1, Valerie M Harris2, Joshua Cavett3, Biji T Kurien3, Ke Liu4, Kristi A. Koelsch5, Lida Radfar6, David M. Lewis7, Donald U. Stone8, C. Erick Kaufman9, Shibo Li10, Barbara M. Segal11, Daniel J Wallace12, Michael Weisman13, Jennifer A. Kelly14, Bernado Pons-Estel15, Roland Jonsson16, Jacques-Eric Gottenberg17, Juan-Manuel Anaya18, Deborah S. Cunninghame-Graham19, Vivian P. Bykerk20, Gideon Hirschfield21, Gang Xie22, Wan-Fai Ng23, Gunnel Nordmark24, Per Eriksson25, Roald Omdal26, Nelson L. Rhodus27, Maureen Rischmueller28, Michael D. Rohrer29, Marie Wahren-Herlenius30, Torsten Witte31, Xavier Mariette32, Christopher J. Lessard33, John B. Harley34, Kathy L. Sivils33, Astrid Rasmussen35, R. Hal Scofield33, Swamy Venturopalli36, Xianglan Lu10, Pamela Hughes37, Andrew J.W. Huang38 and Corinnine Miceli-Richard39, 1Medical Service, US Department of Veterans Affaris Medical Center, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 43333 Burnet Ave., University of Cincinnati & Cincinnati Childre, Cincinnati, OH, 5U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 6Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 7Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 8King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 9Medicine, University of Oklahoam Health Sciences Center, Oklahoma City, OK, 10Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 11Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN, 12Cedars-Sinai Medical Center, West Hollywood, CA, 13Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 14Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 15Sanatorio Parque, Rosario, Argentina, 16Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 17Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, 18Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá, Colombia, 19Department of Medical and Molecular Genetics, King's College London, London, United Kingdom, 20Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 21Centre for Liver Research, Institute of Biomedical Research, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 22Mount Sinai Hospital, Toronto, ON, Canada, 23Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 24Rheumatology, Department of Medical Sciences, Uppsala University, Sweden, Uppsala, Sweden, 25University Hospital, Rheumatology clinic, Linköping, Sweden, 26Department of internal medicine, Clinical Immunology unit, Stavanger, Norway, 27Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 28Rheumatology, Queen Elizabeth Hospital, Adelaide, Australia, 29Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 30Department of Medicine, Experimental Rheumatology Unit, Solna, Sweden, 31Hannover Medical School, Hanover, Germany, 32Rheumatology, Rheumatology department, Bicetre Hospital, Paris-Sud University, Le Kremlin Bicetre, France, 33Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 34Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Childrens Hospital, Cincinnati, OH, 35Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, USA, Oklahoma City, OK, 36Rheumatology, Cedars Syani Medical Center, Los Angeles, CA, 37Division of Oral and Maxillofacial Surgery, Department of Developmental and Surgical Science, University of Minnesota School of Dentistry, Minneapolis, MN, 38Washington University,, St Louis, MO, 39Rheumatology, Université Paris-Sud, Paris, France

    Background/Purpose:  Sjögren’s syndrome and systemic lupus erythematosus (SLE) are chronic, autoimmune diseases that are related by clinical and serological manifestations as well as genetic risks.…
  • Abstract Number: 1079 • 2016 ACR/ARHP Annual Meeting

    Discovery of Novel Autoantigens in Sjogren’s Syndrome with Potential for Subgrouping of Disease

    Peter Schulz-Knappe1, Petra Budde1, Hans-Dieter Zucht1, Heike Göhler1, Klaus Marquart1, Prof. Dr. Matthias Schneider2 and Torsten Witte3, 1Protagen AG, Dortmund, Germany, 2Department of Rheumatology, Univ. Duesseldorf, Duesseldorf, Germany, 3Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a common autoimmune disease with exocrine gland dysfunction and multi-organ involvement. With the growing interest in conducting clinical trials…
  • Abstract Number: 2673 • 2016 ACR/ARHP Annual Meeting

    Glandular Ultrasonography in Primary SjöGren Syndrome: Clinical and Laboratory Correlation

    Tania Fidelix1, Virginia Trevisani2, Adagmar Andriolo3 and Adriano Czapkowski4, 1Evidence Based Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil, 2Health Evidence Based, Escola Paulista de Medicina, São Paulo, Brazil, 3Clinical Laboratories, Escola Paulista de Medicina, Sao Paulo, Brazil, 4Radiology, Radiology Department- Escola Paulista de Medicina, Sao Paulo, Brazil

    Background/Purpose: Primary SjogrenÕs syndrome (pSS) is a chronic autoimmune disorder that is characterized clinically by dryness of the eyes (xerophthalmia) and mouth (xerostomia). The assayÕs…
  • Abstract Number: 3228 • 2016 ACR/ARHP Annual Meeting

    Specific T Cell and B Cell Distributions Characterize Subgroups of Patients with Primary Sjögren’s Syndrome and Are Associated with Disease Activity and Pro-Inflammatory Cytokine Expression

    Lucas Le Lann1, Quentin Simon1, Christophe Jamin1, Maria Orietta Borghi2, Lorenzo Beretta3, Ricard Cervera4, Alain Saraux5, Divi Cornec1, Rik Lories6, Carlo Chizzolini7, Marta E. Alarcon Riquelme8, Jacques-Olivier Pers1 and on behalf of the PRECISESADS Consortium, 1INSERM ERI29, EA2216, Université de Brest, Labex IGO, CHRU Morvan, Brest, France, 2University of Milan, IRCCS Istituto Auxologico Italiano, Milan, Italy, 3Rheumatology, Milan, Italy, 4Department of Autoimmune Diseases, Institut Clínic de Medicina i Dermatologia, Hospital Clínic de Barcelona, Barcelona, Spain, 5Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, 6Laboratory of Tissue Homeostasis and Disease, Skeletal Biology and Engineering Research Center, KU Leuven and University Hospitals Leuven., Leuven, Belgium, 7University hospital of Geneva, Geneva, Switzerland, 8Centro de Genomica e Investigación Oncológica, Pfizer-University of Granada-Junta de Andalucía, Granada, Spain

    Background/Purpose : The goal of the IMI PRECISESADS project is to reclassify individuals affected by systemic autoimmune diseases (SADs) into clusters of molecular, instead of…
  • Abstract Number: 184 • 2016 ACR/ARHP Annual Meeting

    Upregulation and Activation of the IFI16-Sting-IRF3-IFN Pathway in Sjogren’s Salivary Glands

    Brendan Antiochos1, Livia Casciola-Rosen2 and Antony Rosen3, 1Rheumatology, Johns Hopkins University School of Medicine, Maltimore, MD, 2Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Type I IFN expression is known to be upregulated in the salivary glands of patients with SjogrenÕs syndrome, but the upstream stimuli responsible for…
  • Abstract Number: 1080 • 2016 ACR/ARHP Annual Meeting

    B-Cell Clonal Expansions in Parotid Glands of Sjogren’s Patients Are Associated with Increased Numbers of N-Glycosylation Motifs in the Immunoglobulin Heavy Chain Genes

    Annie Visser1, Marieke E. Doorenspleet2, Niek de Vries3, Fred K.L. Spijkervet4, Arjan Vissink5, Hendrika Bootsma6, Frans G.M. Kroese1 and Nicolaas A Bos1, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Dept. of Clinical Immunology & Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 6Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

    Background/Purpose:  Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by chronic inflammation of salivary and lacrimal glands. Patients with pSS have increased clonal…
  • Abstract Number: 2676 • 2016 ACR/ARHP Annual Meeting

    Changes in Salivary Gland Echostructure in Patients with Primary SjöGren’s Syndrome over the Time: A Four-Year Longitudinal Study

    Chiara Baldini1, Nicoletta Luciano2, Francesco Ferro3, Elena Elefante3, Stefano Bombardieri3 and Marta Mosca4, 1Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, 2Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 3Rheumatology Unit, University of Pisa, Pisa, Italy, 4Clinical and Experimental Medicine, University of Pisa, Rheumatology Unit, Pisa, Italy

    Background/Purpose: Salivary gland ultrasonography (SGUS) has recently appeared as a promising tool for a non-invasive diagnosis of primary Sjögren’s syndrome (pSS). However, it is still…
  • Abstract Number: 3229 • 2016 ACR/ARHP Annual Meeting

    Bone Morphogenetic Protein 6 Receptor Inhibition Restores Salivary Gland Function in a Mouse Model of Primary Sjögren’s Syndrome

    Hongen Yin1, Lovika Kalra1, Arif Karim1, Zhennan Lai1, Maria Guimaro1, Lauren Aber1, Bill Swaim1, Sandra Afione1, Alexandria Voigt2, Cuong Nguyen3, Paul Yu4, Donald Bloch5 and John A. Chiorini1, 1Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, 2Department of Pathology and Infectious Diseases, University of Florida, Gainesville, FL, 3Department of Pathology and Infectious Diseases, University of Florida, Bethesda, MD, 4Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 5Center for Immunology and Inflammatory Diseases and the Division of Rheumatology, Allergy, and Immunology of the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose:   Methods:   Results: Elevated BMP6 was found in 63/80 (78.8%) of pSS patients examined in this study. In humans, ALK2 and ALK3 receptors…
  • Abstract Number: 340 • 2016 ACR/ARHP Annual Meeting

    Hydroxychloroquine: A Potential Treatment for Osteoporosis By Osteoclast Inhibition!

    Tim Both1, Paul L. van Daele2 and Bram Van der Eerden1, 1Internal Medicine, Erasmus MC, Rotterdam, Netherlands, 2Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands

    Background/Purpose: We recently showed that patients with primary Sjögren Syndrome (pSS) have significantly higher bone mineral density (BMD) in the lumbar spine and femoral neck…
  • Abstract Number: 1216 • 2016 ACR/ARHP Annual Meeting

    Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness

    John A. Ice1, Indra Adrianto1, Astrid Rasmussen1, Kiely Grundahl2, Michelle L. Joachims3, Graham B. Wiley1, Jennifer A. Kelly1, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Barbara M. Segal8, Nelson L. Rhodus9, Joel M. Guthridge3, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James1,16,17, Courtney G. Montgomery1, R. Hal Scofield1,17,18, Patrick Gaffney1, Kathy L. Sivils3 and Christopher J. Lessard1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 11Harvard Medical School, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 18US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disorder in which exocrine dysfunction can lead to chronic, debilitating dryness. Expression studies in SS have identified…
  • Abstract Number: 2681 • 2016 ACR/ARHP Annual Meeting

    Clinical and Immunological Characteristics of Primary Sjogren´s Syndrome in Men

    Rebeca Belmonte1, Carlos Sánchez-Piedra2, Monica Fernandez Castro3, Jose Luis Andreu4, Victor Martinez Taboada5, Alejandro Olivé6, José Rosas7, Jorge González Martín8, Esther Ruiz Lucea9, Antonio Naranjo10, Oscar Illera11, Lurdes Romani12, Sheila Melchor13, Begoña Moreira14, Enrique Raya15, Marina Rodriguez16, Natalia Cid17 and on behalf of SJOGRENSER project (GEEAS-SER), 1Rheumatoloy, Hospital Virgen de la Salud, Toledo, Spain, 2Research Unit, Spanish Society of Rheumatology, Madrid, Spain, 3Rheumatology, Hospital Infanta Sofía, Madrid, Spain, 4Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, 5Hospital Marqués de Valdecilla., Santander, Spain, 6Rheumatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, 7Rheumatology, Hospital Marina Baixa, Villajoyosa (Alicante), Spain, 8Rheumatology, Hospital Madrid Norte Sanchinarro, Madrid, Spain, 9Rheumatology, Hospital de Basurto, Bilbao, Spain, 10Rheumatology Division, Hospital Doctor Negrin, Las Palmas GC, Spain, 11Rheumatology, Hospital Universitario Infanta Sofía, Madrid, Spain, 12Hospital Virgen de las Nieves., Granada, Spain, 13Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 14Rheumatology, Hospital de Sierrallana, Torrelavega, Spain, 15Rheumatology Department, Hospital Clínico San Cecilio, Granada, Spain, 16Rheumatology, University Hospital Complex of Vigo, Vigo, Spain, 17Rheumatology, Hospital de Valme, Sevilla, Spain

    Background/Purpose: Primary Sjögren syndrome (pSS) is a systemic autoimmune disease involving primarily the exocrine glandular system. pSS in men is uncommon. Data of pSS in…
  • Abstract Number: 3239 • 2016 ACR/ARHP Annual Meeting

    Expression of IFN-Regulated Genes in Autoantibody Exposed Babies in Utero

    Malin Hedlund1, Gudny-Ella Thorlacius1, Margarita Ivanchenko1, Vijole Ottosson1, Amina Ossoinak1, Linda Lagnefeldt1, Joanna Tingstrom1, Alexander Espinosa1, Lars Rönnblom2, Maija-Leena Eloranta2, Sven-Erik Sonesson1 and Marie Wahren-Herlenius3, 1Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Stockholm, Sweden, 2Uppsala University, Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala, Sweden, 3Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden

    Background/Purpose: Ro/SSA autoantibodies and an IFN signature are commonly present in women with Sjögren’s syndrome and SLE. During pregnancy, the autoantibodies are transported across the…
  • Abstract Number: 656 • 2016 ACR/ARHP Annual Meeting

    ERdj5 Function Is Involved in Inflammatory Manifestations of Sjögren’s Syndrome in the Salivary Glands

    Eirini Apostolou1, Petros Moustardas2, Takao Iwawaki3, Giannis Spyrou2 and Athanasios G. Tzioufas4, 1Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 2Clinical and Experimental Medicine, Division of Microbiology and Molecular Medicine, Linköping University, Linköping, Sweden, 3Life Science, Division of Cell Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 4School of Medicine, Pathophysiology Department, National and Kapodistrian University of Athens, Athens, Greece

    Background/Purpose:  Sjögren’s syndrome is a chronic autoimmune disorder that affects mainly the exocrine glands. The initiation and causative agents are still unknown. Endoplasmic Reticulum (ER)…
  • Abstract Number: 1217 • 2016 ACR/ARHP Annual Meeting

    Identification of Sjogren’s Syndrome-Associated Long Non-Coding RNAs That Are Co-Expressed with Key Protein-Coding Transcripts Involved in Dysregulated Interferon Responses

    John A. Ice1, Indra Adrianto1, Michelle L. Joachims2, Jennifer A. Kelly2, Graham B. Wiley1, Astrid Rasmussen1, Kiely Grundahl3, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Joel M. Guthridge2, Barbara M. Segal8, Nelson L. Rhodus9, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James16,17,18, Courtney G. Montgomery1, R. Hal Scofield1,18,19, Patrick Gaffney1, Kathy L. Sivils2,16 and Christopher J. Lessard1,16, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Harvard Medical School, Boston, MA, 11Massachusetts Eye and Ear Infirmary, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 18Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 19US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: The “interferon signature”, marked by transcriptional upregulation of interferon (IFN)-inducible (IFI) genes, is a common finding in Sjögren’s syndrome (SS) that is associated with…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 26
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology